Risedronate in Improving Bone Mineral Density and Bone Health in Postmenopausal Women With Ductal Carcinoma In Situ Enrolled in Clinical Trial CRUK-IBIS-II-DCIS

Clinical trial NCT00324714 · WITHDRAWN

Trial details

NCT number: NCT00324714
Sponsor: ETOP IBCSG Partners Foundation
Status: WITHDRAWN
Phase: Phase 3
Study type: INTERVENTIONAL

Breast Cancer Osteoporosis

Start date: 2003-02-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.